Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Hot Flashes 1Breast Neoplasms 1

Interventions

Venlafaxine Hydrochloride 2Sodium Chloride 2Magnesium Oxide 2Gabapentin 2Bupivacaine 2fezolinetant 1black cohosh root extract 1bazedoxifene 1Tamoxifen 1Soybean Proteins 1Solifenacin Succinate 1Isoflavones 1Hypericum extract LI 160 1Estrogens, Conjugated (USP) 1Estetrol 1Daptomycin 1Clonidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hot Flashes × Estetrol × Clear all
NCT03361969 2021-06-18

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

Pantarhei Oncology B.V.

Phase 2 Completed
63 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡